Cargando…
Time to Call into Question the Fundus-based Evaluation of Diabetic Retinopathy after Intravitreal Injections
Autor principal: | Tadayoni, Ramin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PUBLISHED BY KNOWLEDGE E
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001029/ https://www.ncbi.nlm.nih.gov/pubmed/32095202 http://dx.doi.org/10.18502/jovr.v15i1.5971 |
Ejemplares similares
-
Need for a New Classification of Diabetic Retinopathy
por: Jampol, Lee M., et al.
Publicado: (2021) -
Efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study
por: Mirshahi, Ahmad, et al.
Publicado: (2019) -
Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
por: Suren, Elcin, et al.
Publicado: (2020) -
Ghost cell glaucoma after intravitreous injection of ranibizumab in proliferative diabetic retinopathy
por: Xu, Jun, et al.
Publicado: (2020) -
Evaluation of Fundus Blood Flow Perfusion in Patients with Diabetic Retinopathy after PPV with Fundus Color Doppler Based on Big Data Mining
por: Wang, Xin, et al.
Publicado: (2022)